Surgery Partners, Inc.
SGRY
Updated: 23/09/2026, 16:56:10
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
No summaries found.
- Share price
- $15.13
- Market cap
- $1.98B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- J. Eric Evans
- Employees
- 16,000
- IPO date
- 30/09/2015
- Beta
- 1.92
- Last dividend
- $0.00
- Day range
- $15.05 – $15.82
- 52-week range
- $11.41 – $23.44
- 1-day performance
- -4.27%
- 1-year performance
- 32.56%
- Current drawdown (1Y)
- -35.47%
- CIK
- 0001638833
- CUSIP
- 86881A100
- ISIN
- US86881A1007
- Created
- 07/12/2025, 14:12:40
- Last update
- 23/09/2026, 16:56:10
Track Surgery Partners, Inc. with an AI analyst
See which prediction-market events move SGRY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 05/05/2026, 17:41:21
Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research • STOCK • 05/05/2026, 12:15:57
SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES
PRNewsWire • STOCK • 01/04/2026, 11:00:00
Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
GlobeNewsWire • STOCK • 26/03/2026, 08:30:00
SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES
PRNewsWire • STOCK • 18/03/2026, 10:45:00
Surgery Partners, Inc. (SGRY) Presents at Barclays 28th Annual Global Healthcare Conference Prepared Remarks Transcript
Seeking Alpha • STOCK • 10/03/2026, 18:10:20
Fraud Investigation Opened: Levi & Korsinsky Investigates Surgery Partners, Inc. (SGRY) on Behalf of Shareholders
Newsfile Corp • STOCK • 09/03/2026, 16:15:00
Surgery Partners, Inc. (NASDAQ: SGRY) Maintains "Buy" Rating Amid Investigation
Market Data • Market Data • 04/03/2026, 21:02:56
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS
PRNewsWire • STOCK • 04/03/2026, 17:00:00
Surgery Partners, Inc. (NASDAQ: SGRY) Faces Challenges but Shows Potential for Recovery
Market Data • Market Data • 03/03/2026, 20:15:46
Surgery Partners, Inc. (SGRY) Q4 2025 Earnings Call Transcript
Seeking Alpha • STOCK • 03/03/2026, 13:22:13
Surgery Partners (SGRY) Lags Q4 Earnings Estimates
Zacks Investment Research • STOCK • 02/03/2026, 19:35:12